# The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation

> **NCT07323446** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Emotional Dysregulation

## Interventions

- **DRUG:** N-Acetyl Cysteine (NAC)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07323446
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-01
- **Primary completion:** 2030-01-01
- **Final completion:** 2030-01-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07323446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07323446, "The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07323446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*